BIO-key International reported Q2 2026 revenues of $1.9 million, a 13% increase year-over-year, driven by a 53% rise in license fee revenue to $1.2 million. Gross margin improved to 87% from 73%, and the net loss narrowed 51% to $(577K). Approximately $0.8 million in hardware revenue was delayed to H2 2026. The company also raised approximately $2.5 million through a warrant exercise at $4.06 per share, bringing cash reserves above $4.5 million. BIO-key operates in the identity and access management (IAM) and biometric authentication technology industry.
